RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES. (12th June 2019) - Kelly, K.M.; Daw, S.; Mauz‐Körholz, C.; Mascarin, M.; Michel, G.; Cooper, S.; Beishuizen, A.; Leger, K.J.; Garaventa, A.; Buffardi, S.; Brugières, L.; Harker‐Murray, P.; et al.